Pancreatic enzyme supplementation versus placebo for improvement of gastrointestinal symptoms in non-responsive celiac disease: A cross-over randomized controlled trial
Shakira Yoosuf(Chettinad Health City), Ciarán P. Kelly(Met Éireann), Caitlin Barrett(Beth Israel Deaconess Medical Center), Amélie Therrien(Beth Israel Deaconess Medical Center), Sarah E. Madoff(Beth Israel Deaconess Medical Center), Jocelyn A. Silvester, Joshua Hansen(Boston Children's Hospital), Prashant Singh(Michigan Medicine), Melinda Dennis, Daniel A. Leffler(Beth Israel Deaconess Medical Center), Konstantinos Papamichael(Beth Israel Deaconess Medical Center), Satya Kurada(Beth Israel Deaconess Medical Center)
Cited by 7
Related Papers
Clinical Practice Guidelines for Clostridium difficile Infection in Adults and Children: 2017 Update by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA)
|Clinical Infectious Diseases|2017|2.7k
Global Prevalence of Celiac Disease: Systematic Review and Meta-analysis
|Clinical Gastroenterology and Hepatology|2018|1.7k
Diagnosis and management of adult coeliac disease: guidelines from the British Society of Gastroenterology
|Gut|2014|1.1k
Body-Mass Index and Symptoms of Gastroesophageal Reflux in Women
|New England Journal of Medicine|2006|664